Torsten Haack

1.0k total citations
27 papers, 663 citations indexed

About

Torsten Haack is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Torsten Haack has authored 27 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Molecular Biology and 8 papers in Organic Chemistry. Recurrent topics in Torsten Haack's work include Diabetes Treatment and Management (13 papers), Receptor Mechanisms and Signaling (6 papers) and Neuropeptides and Animal Physiology (6 papers). Torsten Haack is often cited by papers focused on Diabetes Treatment and Management (13 papers), Receptor Mechanisms and Signaling (6 papers) and Neuropeptides and Animal Physiology (6 papers). Torsten Haack collaborates with scholars based in Germany, United States and Sweden. Torsten Haack's co-authors include Michael Wagner, Martin Bossart, Philip J. Larsen, Andreas Evers, Gernot Boche, J. Tillner, Lenore Teichert, Lothar Erdinger, Stefanie Keil and Youssef Hijazi and has published in prestigious journals such as Angewandte Chemie International Edition, Advanced Drug Delivery Reviews and Diabetes.

In The Last Decade

Torsten Haack

27 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Torsten Haack Germany 15 358 288 158 115 107 27 663
Rajesh Bahekar India 16 240 0.7× 285 1.0× 145 0.9× 68 0.6× 278 2.6× 56 716
Tomoyuki Odani Japan 11 215 0.6× 347 1.2× 162 1.0× 47 0.4× 90 0.8× 14 542
Johan Malm United States 16 545 1.5× 313 1.1× 90 0.6× 41 0.4× 129 1.2× 25 995
Won Hoon Jung South Korea 18 146 0.4× 220 0.8× 71 0.4× 53 0.5× 209 2.0× 40 720
Moh Tadayyon Germany 11 487 1.4× 441 1.5× 269 1.7× 42 0.4× 66 0.6× 12 987
Bryce A. Harrison United States 14 271 0.8× 340 1.2× 180 1.1× 155 1.3× 272 2.5× 19 790
K. W. M. Lawrie United Kingdom 10 135 0.4× 380 1.3× 334 2.1× 434 3.8× 104 1.0× 27 875
Dale E. Sharp United States 12 481 1.3× 361 1.3× 324 2.1× 74 0.6× 57 0.5× 13 878
Fuyong Du United States 11 258 0.7× 238 0.8× 194 1.2× 79 0.7× 147 1.4× 17 548
Holger Heitsch Germany 13 229 0.6× 277 1.0× 52 0.3× 123 1.1× 106 1.0× 20 756

Countries citing papers authored by Torsten Haack

Since Specialization
Citations

This map shows the geographic impact of Torsten Haack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torsten Haack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torsten Haack more than expected).

Fields of papers citing papers by Torsten Haack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Torsten Haack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torsten Haack. The network helps show where Torsten Haack may publish in the future.

Co-authorship network of co-authors of Torsten Haack

This figure shows the co-authorship network connecting the top 25 collaborators of Torsten Haack. A scholar is included among the top collaborators of Torsten Haack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Torsten Haack. Torsten Haack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Eriksson, Olof, Irina Velikyan, Torsten Haack, et al.. (2021). Glucagon Like Peptide-1 receptor imaging in individuals with Type 2 Diabetes. Journal of Nuclear Medicine. 63(5). jnumed.121.262506–jnumed.121.262506. 6 indexed citations
3.
Kannt, Aimo, Andreas Nygaard Madsen, Ralf Elvert, et al.. (2020). Incretin combination therapy for the treatment of non‐alcoholic steatohepatitis. Diabetes Obesity and Metabolism. 22(8). 1328–1338. 33 indexed citations
4.
Eriksson, Olof, Torsten Haack, Youssef Hijazi, et al.. (2020). Receptor occupancy of dual glucagon-like peptide 1/glucagon receptor agonist SAR425899 in individuals with type 2 diabetes. Scientific Reports. 10(1). 16758–16758. 34 indexed citations
5.
Eriksson, Olof, Irina Velikyan, Torsten Haack, et al.. (2020). Imaging of the Glucagon Receptor in Subjects with Type 2 Diabetes. Journal of Nuclear Medicine. 62(6). 833–838. 8 indexed citations
6.
Wolff, Martin, Klaus Gast, Robert Seckler, et al.. (2020). Self-Assembly of Exendin-4-Derived Dual Peptide Agonists is Mediated by Acylation and Correlated to the Length of Conjugated Fatty Acyl Chains. Molecular Pharmaceutics. 17(3). 965–978. 6 indexed citations
7.
Wagner, Michael, J. Tillner, Gunnar Antoni, et al.. (2020). Automated GMP-Compliant Production of [68Ga]Ga-DO3A-Tuna-2 for PET Microdosing Studies of the Glucagon Receptor in Humans. Pharmaceuticals. 13(8). 176–176. 4 indexed citations
8.
Eriksson, Olof, Irina Velikyan, Torsten Haack, et al.. (2019). Assessment of glucagon receptor occupancy by Positron Emission Tomography in non-human primates. Scientific Reports. 9(1). 14960–14960. 7 indexed citations
9.
Velikyan, Irina, Torsten Haack, Martin Bossart, et al.. (2019). First-in-class positron emission tomography tracer for the glucagon receptor. EJNMMI Research. 9(1). 17–17. 18 indexed citations
10.
Elvert, Ralf, Andreas W. Herling, Martin Bossart, et al.. (2018). Running on mixed fuel‐dual agonistic approach of GLP‐1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non‐human primates. Diabetes Obesity and Metabolism. 20(8). 1836–1851. 30 indexed citations
11.
Evers, Andreas, Martin Bossart, Stefania Pfeiffer‐Marek, et al.. (2018). Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Specifically Optimized for Multidose Formulations. Journal of Medicinal Chemistry. 61(13). 5580–5593. 40 indexed citations
12.
Tillner, J., Maximilian Posch, Frank Wagner, et al.. (2018). A novel dual glucagon‐like peptide and glucagon receptor agonist SAR425899: Results of randomized, placebo‐controlled first‐in‐human and first‐in‐patient trials. Diabetes Obesity and Metabolism. 21(1). 120–128. 135 indexed citations
13.
Urmann, Matthias, et al.. (2016). Oral delivery of diabetes peptides — Comparing standard formulations incorporating functional excipients and nanotechnologies in the translational context. Advanced Drug Delivery Reviews. 106(Pt B). 196–222. 56 indexed citations
14.
Schneider, Christopher, et al.. (2011). Synthesis of Oximidine II by a Copper‐Mediated Reductive Ene–Yne Macrocyclization. Angewandte Chemie International Edition. 50(34). 7855–7857. 15 indexed citations
15.
Ward, Timothy R., Brandon J. Turunen, Torsten Haack, et al.. (2009). Synthesis of a quinolone library from ynones. Tetrahedron Letters. 50(47). 6494–6497. 27 indexed citations
16.
Laursen, Jane B., John Nielsen, Torsten Haack, et al.. (2006). Further Exploration of Antimicrobial Ketodihydronicotinic Acid Derivatives by Multiple Parallel Syntheses. Combinatorial Chemistry & High Throughput Screening. 9(9). 663–681. 3 indexed citations
17.
Haack, Torsten, et al.. (2005). Formal Total Syntheses of the (−)-Salicylihalamides A and B From d-Glucose and l-Rhamnose. The Journal of Organic Chemistry. 70(19). 7592–7604. 11 indexed citations
18.
Haack, Torsten, et al.. (2003). Enantiospecific Formal Total Syntheses of (−)-Salicylihalamides A and B from d-Glucose and l-Rhamnose. Organic Letters. 5(21). 4007–4009. 11 indexed citations
19.
Haack, Torsten, Lothar Erdinger, & Gernot Boche. (2001). Mutagenicity in Salmonella typhimurium TA98 and TA100 of nitroso and respective hydroxylamine compounds. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 491(1-2). 183–193. 29 indexed citations
20.
Klein, Markus, Ulrike Voigtmann, Torsten Haack, Lothar Erdinger, & Gernot Boche. (2000). From mutagenic to non-mutagenic nitroarenes: effect of bulky alkyl substituents on the mutagenic activity of 4-nitrobiphenyl in Salmonella typhimurium. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 467(1). 55–68. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rajesh Bahekar Breakdown of academic impact, for papers by Tomoyuki Odani Breakdown of academic impact, for papers by Johan Malm Breakdown of academic impact, for papers by Won Hoon Jung Breakdown of academic impact, for papers by Moh Tadayyon Breakdown of academic impact, for papers by Bryce A. Harrison Breakdown of academic impact, for papers by K. W. M. Lawrie Breakdown of academic impact, for papers by Dale E. Sharp Breakdown of academic impact, for papers by Fuyong Du Breakdown of academic impact, for papers by Holger Heitsch
Rankless by CCL
2026